These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37119294)

  • 1. Noninvasive differentiation of porto-sinusoidal vascular disorder from cirrhosis: a systematic review.
    Giri S; Singh A; Roy A; Patel RK; Tripathy T; Angadi S
    Abdom Radiol (NY); 2023 Jul; 48(7):2340-2348. PubMed ID: 37119294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension.
    Ferreira-Silva J; Gaspar R; Liberal R; Cardoso H; Macedo G
    Dig Liver Dis; 2023 Jan; 55(1):75-80. PubMed ID: 36280435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of transient elastography in differentiation between porto-sinusoidal vascular liver disease and compensated cirrhosis.
    Zhang G; Ma L; Fu L; Li M; He F; Feng L; Wang M; Jia J; Wang Y; Zhao X
    Liver Int; 2023 Nov; 43(11):2513-2522. PubMed ID: 37614162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
    Lampichler K; Semmler G; Wöran K; Simbrunner B; Jachs M; Hartl L; Bauer DJM; Balcar L; Burghart L; Trauner M; Tamandl D; Ba-Ssalamah A; Mandorfer M; Reiberger T; Scheiner B; Scharitzer M
    Eur Radiol; 2023 Feb; 33(2):1422-1432. PubMed ID: 36166087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI.
    Kang JH; Kim DH; Kim SY; Kang HJ; Lee JB; Kim KW; Lee SS; Choi J; Lim YS
    Abdom Radiol (NY); 2021 May; 46(5):1891-1903. PubMed ID: 33095310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
    Elkrief L; Lazareth M; Chevret S; Paradis V; Magaz M; Blaise L; Rubbia-Brandt L; Moga L; Durand F; Payancé A; Plessier A; Chaffaut C; Valla D; Malphettes M; Diaz A; Nault JC; Nahon P; Audureau E; Ratziu V; Castera L; Garcia Pagan JC; Ganne-Carrie N; Rautou PE;
    Hepatology; 2021 Jul; 74(1):364-378. PubMed ID: 33345307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.
    Nicoară-Farcău O; Rusu I; Stefănescu H; Tanțău M; Badea RI; Procopeț B
    World J Gastroenterol; 2020 Jun; 26(22):3000-3011. PubMed ID: 32587444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of ultrasonography-elastography score to suspect porto-sinusoidal vascular disease in patients with portal vein thrombosis.
    Gioia S; De Santis A; d'Amati G; Nardelli S; Spagnoli A; Rocco AD; Ridola L; Riggio O
    Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):20-24. PubMed ID: 37468349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: A case-control study.
    Valainathan SR; Sartoris R; Elkrief L; Magaz M; Betancourt F; Pellegrino S; Nivolli A; Dioguardi Burgio M; Flattet Y; Terraz S; Drilhon N; Lazareth M; Herrou J; Bruno O; Payance A; Plessier A; Durand F; Ronot M; Valla DC; Paradis V; Garcia-Pagan JC; Vilgrain V; Rautou PE
    Hepatology; 2022 Aug; 76(2):418-428. PubMed ID: 35092315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
    Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
    Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porto-sinusoidal vascular disorder (PSVD): Application of new diagnostic criteria in a multicenter cohort of patients.
    Gioia S; Baiocchini A; d'Amati G; Tavano D; Ridola L; Nardelli S; de Felice I; Lapenna L; Merli M; Pellicelli A; Giannelli V; Riggio O
    Dig Liver Dis; 2024 Feb; 56(2):291-296. PubMed ID: 37550100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder.
    Pugliese N; Ponziani FR; Cerini F; di Tommaso L; Turati F; Maggioni M; Manini MA; Santopaolo F; Bianco C; Masetti C; Giustiniani MC; La Vecchia C; Valenti L; Terracciano L; Viganò M; Aghemo A
    JHEP Rep; 2024 Sep; 6(9):101150. PubMed ID: 39263328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porto-sinusoidal vascular disorder.
    De Gottardi A; Sempoux C; Berzigotti A
    J Hepatol; 2022 Oct; 77(4):1124-1135. PubMed ID: 35690264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric porto-sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences.
    Di Giorgio A; Matarazzo L; Sonzogni A; Nicastro E; Pietrobattista A; Cananzi M; Gaio P; Sciveres M; Di Leo G; Iorio R; Marseglia A; Carioli G; Maggiore G; Guido M; D'Antiga L
    Liver Int; 2023 Jul; 43(7):1523-1536. PubMed ID: 37157951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving Understanding of Noncirrhotic Portal Hypertension.
    Isidro RA; Zhao L
    Surg Pathol Clin; 2023 Sep; 16(3):549-563. PubMed ID: 37536888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored.
    Zhang Y; Liu H; Xiong Q; Zhong Y; Liu D; Chen W; Yang Y
    Medicine (Baltimore); 2024 Sep; 103(39):e39819. PubMed ID: 39331914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porto-sinusoidal Vascular Disease: Classification and Clinical Relevance.
    Premkumar M; Anand AC
    J Clin Exp Hepatol; 2024; 14(5):101396. PubMed ID: 38601747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked.
    Olivas P; Perez-Campuzano V; Orts L; Montironi C; Magaz M; Ruiz P; Shalaby S; Ojeda A; Rosich P; Baiges A; Turon F; Lens S; García Pagán JC; Hernández-Gea V
    JHEP Rep; 2024 Mar; 6(3):100996. PubMed ID: 38384671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology.
    Cerda Reyes E; González-Navarro EA; Magaz M; Muñoz-Sánchez G; Diaz A; Silva-Junior G; Triguero A; Lafoz E; Campreciós G; Orts L; Perez-Campuzano V; Seijo S; Rubio L; Turon F; Baiges A; Hernández-Gea V; Álvarez-Larran A; Juan M; Garcia-Pagan JC
    Liver Int; 2021 Sep; 41(9):2171-2178. PubMed ID: 34173316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porto-Sinusoidal Vascular Disease: A New Nomenclature Different from Idiopathic Non-Cirrhotic Portal Hypertension.
    Liu J; Zhang Q; Liu Y; Ma HX; Han X; Ma Y; Zhao LL; Li J
    Diagnostics (Basel); 2024 Sep; 14(18):. PubMed ID: 39335732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.